HHS Announces Funding to Tackle Methodological Challenges in Clinical Trials for Rapid-Acting Psychotropic Drugs
Grants
Copyright © Targeted News Service, 2026
Copyright © Targeted News Service, 2026
2026-05-01
Bailey Malota
WASHINGTON, May 1 -- The U.S. Department of Health and Human Services, through the National Institutes of Health, has launched a grant opportunity aimed at addressing the methodological challenges associated with clinical trials of rapid-acting psychotropic interventional drugs (RAPIDs). The initiative seeks to support innovative research that enhances the scientific rigor and effectiveness of clinical trials in this emerging field.
The funding, available under the R01 Clinical Tria . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, May 1 -- The U.S. Department of Health and Human Services, through the National Institutes of Health, has launched a grant opportunity aimed at addressing the methodological challenges associated with clinical trials of rapid-acting psychotropic interventional drugs (RAPIDs). The initiative seeks to support innovative research that enhances the scientific rigor and effectiveness of clinical trials in this emerging field.
The funding, available under the R01 Clinical Tria . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com